The Mucin Paradox: Decoding the Molecular Strategies of Akkermansia muciniphila in Health and Disease
5 affiliations
- 1Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia
- 2Autlan Regional Hospital, Jalisco Health Services, Autlan 48900, Jalisco, Mexico
- 3Centre of Excellence in Bionanoscience, King Abdulaziz University, Jeddah 21589, Saudi Arabia
- 4Department of Molecular Medicine and USF Health Byrd Alzheimer’s Research Institute, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA
- 5Therapeutic and Protective Proteins Laboratory, Protein Research Department, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications (SRTA City), New Borg EL-Arab 21934, Alexandria, Egypt
Abstract
Akkermansia muciniphila is a next-generation probiotic linked to intestinal barrier integrity and host metabolic well-being. However, the mechanisms underlying its mucin utilization remain incompletely understood. In particular, the temporal hierarchy of enzyme deployment, the subcellular and extracellular-vesicle localization of individual mucin-degrading enzymes (MDEs), the fine substrate specificity of glycoside hydrolases toward distinct O-glycan linkages, and the strain-dependent differences in mucinolytic capacity have yet to be resolved. This review integrates genomic, biochemical, and metabolic data to show how A. muciniphila mucin-degrading enzymes (MDEs) degrade mucus, releasing nutrients that support A. muciniphila growth and fermentation (acetate and propionate) and cross-feeding by other bacteria, including butyrate producers. It also highlights that A. muciniphila exhibits a dual nature: it safely stimulates regulated mucus degradation, improves barrier integrity, and feeds beneficial microbes. In contrast, in specific experimental contexts, such as fiber-deprived or high-sugar murine models, dietary fiber shortage or metabolic stress has been associated with increased mucus degradation, a thinner mucus layer, and greater susceptibility to inflammation and pathogens. The probiotic effects of A. muciniphila against metabolic and inflammatory conditions may involve regulated mucin degradation, but benefits may also arise from mechanisms beyond active mucin degradation, including bacterial surface proteins and pasteurized preparations. Unlocking the safe therapeutic potential of this bacterium requires mapping out the spatial, temporal, and strain-specific details of these enzymes. Future research should combine multi-omics and host-interaction studies to clarify enzyme hierarchy, vesicle delivery, and context-dependent impacts.
Related
- α‑Aminophosphonates in anticancer drug discovery: synthetic strategies, anticancer activities, structure–activity relationships and molecular mechanisms
- Strategies towards designing visible and near-infrared light driven molecular motors.
- Silk Fibroin–Polyphenol Gels and Hydrogels: Molecular Interactions, Gelation Strategies, Responsive Behaviors, and Multifunctional Applications
- Targeting virus–glycan recognition in influenza viruses and coronaviruses: from the molecular principles to glycomimetic antivirals strategies
- Nanomaterial-based therapeutic strategies for systemic autoimmune rheumatic diseases: from molecular mechanisms to preclinical translation
BibTeX
@article{alarjani2026mucin,
title = {{The Mucin Paradox: Decoding the Molecular Strategies of Akkermansia muciniphila in Health and Disease}},
author = {Hassan Alarjani and Nawaf S. Alsulami and Hanan A. Alshamrani and Ehab H. Mattar and Alberto Rubio-Casillas and Bassam O. Aljohny and Raed Albiheyri and Faisal Al-Sarraj and Ali Zari and Vladimir N. Uversky and Elrashdy M. Redwan},
journal = {Molecules},
year = {2026},
month = nov,
doi = {10.3390/molecules31213945},
url = {https://www.mdpi.com/1420-3049/31/21/3945},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - The Mucin Paradox: Decoding the Molecular Strategies of Akkermansia muciniphila in Health and Disease
AU - Hassan Alarjani
AU - Nawaf S. Alsulami
AU - Hanan A. Alshamrani
AU - Ehab H. Mattar
AU - Alberto Rubio-Casillas
AU - Bassam O. Aljohny
AU - Raed Albiheyri
AU - Faisal Al-Sarraj
AU - Ali Zari
AU - Vladimir N. Uversky
AU - Elrashdy M. Redwan
PY - 2026
DA - 2026/11/02
JO - Molecules
DO - 10.3390/molecules31213945
UR - https://www.mdpi.com/1420-3049/31/21/3945
AB - Akkermansia muciniphila is a next-generation probiotic linked to intestinal barrier integrity and host metabolic well-being. However, the mechanisms underlying its mucin utilization remain incompletely understood. In particular, the temporal hierarchy of enzyme deployment, the subcellular and extracellular-vesicle localization of individual mucin-degrading enzymes (MDEs), the fine substrate specificity of glycoside hydrolases toward distinct O-glycan linkages, and the strain-dependent differences in mucinolytic capacity have yet to be resolved. This review integrates genomic, biochemical, and metabolic data to show how A. muciniphila mucin-degrading enzymes (MDEs) degrade mucus, releasing nutrients that support A. muciniphila growth and fermentation (acetate and propionate) and cross-feeding by other bacteria, including butyrate producers. It also highlights that A. muciniphila exhibits a dual nature: it safely stimulates regulated mucus degradation, improves barrier integrity, and feeds beneficial microbes. In contrast, in specific experimental contexts, such as fiber-deprived or high-sugar murine models, dietary fiber shortage or metabolic stress has been associated with increased mucus degradation, a thinner mucus layer, and greater susceptibility to inflammation and pathogens. The probiotic effects of A. muciniphila against metabolic and inflammatory conditions may involve regulated mucin degradation, but benefits may also arise from mechanisms beyond active mucin degradation, including bacterial surface proteins and pasteurized preparations. Unlocking the safe therapeutic potential of this bacterium requires mapping out the spatial, temporal, and strain-specific details of these enzymes. Future research should combine multi-omics and host-interaction studies to clarify enzyme hierarchy, vesicle delivery, and context-dependent impacts.
SN - 1420-3049
ER -